Correlation Between 126408HV8 and BioNTech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both 126408HV8 and BioNTech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 126408HV8 and BioNTech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CSX 45 15 NOV 52 and BioNTech SE, you can compare the effects of market volatilities on 126408HV8 and BioNTech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 126408HV8 with a short position of BioNTech. Check out your portfolio center. Please also check ongoing floating volatility patterns of 126408HV8 and BioNTech.

Diversification Opportunities for 126408HV8 and BioNTech

-0.11
  Correlation Coefficient

Good diversification

The 3 months correlation between 126408HV8 and BioNTech is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding CSX 45 15 NOV 52 and BioNTech SE in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioNTech SE and 126408HV8 is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CSX 45 15 NOV 52 are associated (or correlated) with BioNTech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioNTech SE has no effect on the direction of 126408HV8 i.e., 126408HV8 and BioNTech go up and down completely randomly.

Pair Corralation between 126408HV8 and BioNTech

Assuming the 90 days trading horizon CSX 45 15 NOV 52 is expected to under-perform the BioNTech. But the bond apears to be less risky and, when comparing its historical volatility, CSX 45 15 NOV 52 is 1.85 times less risky than BioNTech. The bond trades about -0.07 of its potential returns per unit of risk. The BioNTech SE is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  10,873  in BioNTech SE on September 12, 2024 and sell it today you would earn a total of  812.00  from holding BioNTech SE or generate 7.47% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy90.48%
ValuesDaily Returns

CSX 45 15 NOV 52  vs.  BioNTech SE

 Performance 
       Timeline  
CSX 45 15 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CSX 45 15 NOV 52 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Bond's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for CSX 45 15 NOV 52 investors.
BioNTech SE 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in BioNTech SE are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, BioNTech showed solid returns over the last few months and may actually be approaching a breakup point.

126408HV8 and BioNTech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with 126408HV8 and BioNTech

The main advantage of trading using opposite 126408HV8 and BioNTech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 126408HV8 position performs unexpectedly, BioNTech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioNTech will offset losses from the drop in BioNTech's long position.
The idea behind CSX 45 15 NOV 52 and BioNTech SE pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Complementary Tools

Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets